Laurent Cotte - Infectious Diseases

Author Information

Laurent Cotte is a distinguished researcher affiliated with the Department of Infectious Diseases at Croix-Rousse Hospital, part of the Hospices Civils de Lyon in Lyon, France. He is also associated with INSERM U1052 in Lyon, France. His work primarily focuses on the field of infectious diseases, contributing significantly to the understanding and management of HIV, HCV, and other related infections.

Research Contributions

Laurent Cotte has made substantial contributions to the field of infectious diseases, with a particular focus on HIV and HCV coinfections and their management. His research encompasses a wide range of topics, including the epidemiology of HIV-HCV coinfection, the impact of combination antiretroviral therapy, and the use of PrEP in preventing HIV transmission. Noteworthy among his recent works are studies on the epidemiology of HIV-HCV coinfection in France, the effects of cannabis use in people living with HIV who have achieved HCV cure, and the clinical characteristics of healthcare workers with suspected COVID-19. His research aims to improve the understanding of these diseases and inform better clinical practices.

Aliases

Laurent Cotte is also known under the aliases L Cotte and L. Cotte. These variations are often used in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Total Papers	198
Total Citations	6284
H-index	34

Publications:

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)

DOI: 10.1186/s12981-022-00440-9

Year: 2022

Microelimination or not? The changing epidemiology of HIV-HCV coinfection in France 2012-2018.

DOI: 10.1093/cid/ciaa1940

Year: 2021

Progressive multifocal leukoencephalopathy in patients with immunovirological control and at least 6 months of combination antiretroviral therapy

DOI: 10.1097/QAD.0000000000003145

Year: 2021

What are the situational and behavioral factors associated with condomless anal sex without on-demand PrEP in MSM?: Erratum.

DOI: 10.1097/01.aids.0000724468.18549.1a

Year: 2021

Publisher Correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study

DOI: 10.1038/s41598-021-99051-z

Year: 2021

Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study

DOI: 10.1038/s41598-021-93828-y

Year: 2021

No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study.

DOI: 10.1093/jac/dkab061

Year: 2021

Factors associated with being overweight and obesity in people living with HIV on antiretroviral therapy : socio-clinical, inflammation, and metabolic markers.

DOI: 10.1093/infdis/jiab151

Year: 2021

Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY)

DOI: 10.1093/ofid/ofab085

Year: 2021

Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trial.

DOI: 10.1093/jac/dkab253

Year: 2021

What Are the Benefits of Early Detection?

How is HFMD Diagnosed?

What Challenges Does HTS Face?

Which Diseases Have Been Eradicated?

How Do Aedes Mosquitoes Transmit Diseases?

How Can Ventilation Be Optimized in Public Spaces?

How Can E. Coli Infections be Prevented?

What Topics are Covered During Training?

How Do Fungal Pathogens Affect Us?

What are the Challenges in Studying Parasite DNA?

Partnered Content Networks

Relevant Topics